Application of acting transmembrane protein in spermatogenesis period to diagnosis or treatment of male fertility defects

By detecting the expression and activity of Tmem232 gene and protein, the problem of unrecognized key factors in mammalian fertility is solved, and gender-oriented diagnostic methods are provided, which identify and predict fertility defects and promote the treatment of infertility disorders.

CN119082282APending Publication Date: 2024-12-06SHANDONG UNIV
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202310667269.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-06-05
Publication Date
2024-12-06

AI Technical Summary

Technical Problem

The prior art has not yet effectively understood and detected key factors in mammalian male fertility, which makes it difficult to diagnose and predict infertility disorders, especially the role of the Tmem232 gene in sperm formation and vitality is not fully understood.

Method used

By detecting the expression and activity of the Tmem232 gene and its encoded protein, it provides gender-dependent diagnostic methods and kits for identifying the presence of fertility defects such as infertility disorders, including detection of gene abnormalities and protein expression, Mass spectrometry, microarray method, sequencing method and PCR are used.

Benefits of technology

Effectively identifying and diagnosing fertility defects in mammals, especially infertility disorders caused by mutations in Tmem232, provides gender-targeted diagnostic and prediction methods, and promotes the development of therapeutic methods for targeted male sterile individuals with targeted gene mutations.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119082282A_ABST
    Figure CN119082282A_ABST
Patent Text Reader

Abstract

The present invention provides methods for diagnosing or predicting a fertility defect, such as infertility, in a mammalian subject by detecting Tmem232. The invention also provides kits and instruments for diagnosing or predicting fertility defects, such as infertility disorders, in mammalian individuals by detecting Tmem232. The invention finds and proves that sperm morphological abnormality and flagellum structure abnormality cause sperm motility abnormality and affect fertility of male mammals for the first time, thereby providing a method for diagnosing infertility of mammals including humans, and promoting development of a new treatment method for male infertility individuals affected by gene mutation.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of diseases and diagnosis. Specifically, the present invention relates to methods and kits for diagnosing or treating fertility defects in mammals, especially humans. Background Art

[0002] Male mammalian fertility depends on the successful production of motile sperm that carry a complete paternal genome and are able to fertilize the egg. Spermatozoa are produced through a complex process called spermatogenesis. This process can be divided into three major steps: mitosis (spermatogonia proliferation), meiosis (chromosome number reduction from diploid to haploid), and spermiogenesis (transformation of spermatids into spermatozoa). During spermiogenesis, round spermatids undergo a complex series of cytological events to transform into sperm.

[0003] Existing studies have found that multiple genes in the transmembrane protein family play a role in spermatogenesis and sperm-egg fusion, such as Tmem16e, Tmem95, and Tmem190. The protein TMEM16E encoded by Tmem16e is expressed in the sperm tail. Male mice with Tmem16e knockout have reduced fertilization ability and sperm motility. As a member of the transmembrane protein family gene, Tmem95 encodes a protein that is specifically expressed in the testis. Male mice with Tmem95 knockout are infertile. Studies have found that this gene plays an important role in the fusion of sperm and egg. The protein TMEM190 encoded by Tmem190 is also specifically expressed in the testis, located in the acrosomal membrane of the sperm head, and participates in the sperm-egg fusion process.

[0004] This field also needs to have a better understanding of the male spermatogenesis process and participating factors in mammals, so as to detect and predict reproductive disorders such as infertility. Summary of the invention

[0005] The applicant first discovered that Tmem232 is essential for the fertility of male mammals. Tmem232 gene knockout leads to abnormal sperm morphology and flagella structure, which in turn leads to abnormal sperm motility, affecting the fertility of male mammals. The applicant revealed that male mammals lacking Tmem232 have reduced sperm motility and male infertility.

[0006] The applicant thus provides a method for diagnosing fertility defects such as infertility in mammals, including humans, and further promotes the development of new treatments for male infertile individuals affected by gene mutations. Thus, the inventor provides a method for diagnosing or treating fertility defects such as infertility in mammals, especially humans.

[0007] Specifically, the present invention provides a method for diagnosing or predicting fertility defects such as infertility disorders in mammalian individuals of different sexes, which comprises detecting Tmem232 of the test individual.

[0008] TMEM232, sometimes also written as Tmem232 in this article, is transmembrane protein 232. The Tmem232 gene encoding TMEM232 is highly conserved in mammals. Among them, the Gene ID of the human Tmem232 gene is 642987; the Gene ID of the mouse Tmem232 gene is 381107.

[0009] In the application (including methods and related kits or instruments and devices) provided by the present invention for diagnosing fertility defects in mammals by detecting Tmem232 of the test individual, whether the Tmem232 of the test individual is abnormal is detected, including comparing the activity of the subject's Tmem232 gene or its regulatory factor, or the expression of TMEM232 protein, or comparing with the situation of the gene or protein in normal people in the general or specific group. If there is a significant change, it is judged that an abnormality exists.

[0010] In the present invention, infertility disorders include but are not limited to teratozoospermia, azoospermia, oligozoospermia, asthenozoospermia, asthenozoospermia and the like.

[0011] In the present invention, the mammal can be any mammal, including and not limited to rodents, canines, felines, equines, ovines, bovines, porcines and primates. The mammal typically includes humans.

[0012] The method and kit provided by the present invention are based on the discovery that the effect of Tmem232 on the fertility of mammals is gender-dependent, so the diagnosis and prediction made by the method or kit provided by the present invention are different for mammals of different genders. Therefore, in the method provided by the present invention, it also includes detecting the gender of the subject. In the kit or instrument and device provided by the present invention, it also includes a reagent for detecting the gender of the subject. Methods and reagents for detecting the gender of the subject are well known in the art, for example, including detecting the gender-specific protein or gene of the subject, such as a specific nucleic acid sequence on a sex chromosome, etc.

[0013] In one aspect of the present invention, the method for diagnosing fertility defects provided by the present invention comprises the step of detecting the Tmem232 gene.

[0014] The method for detecting genes used in the present invention is a method commonly used for detecting genes in the art and is not particularly limited. For example, mass spectrometry, microarray, sequencing, and detection methods using base sequence amplification methods such as PCR (polymerase chain reaction) can be cited.

[0015] In addition, the detection of PCR products obtained when PCR is performed using primers specific to each gene can be performed by any method commonly used to detect and quantify PCR products. For example, it can be detected by electrophoresis, by real-time PCR using fluorescent intercalators such as SYBR Green, or by single molecule fluorescence analysis.

[0016] The polynucleotide that can be used as the primer or probe for detecting gene is not particularly limited as long as it can be a polynucleotide that hybridizes with the partial region comprising the gene or its complementary strand. The design of polynucleotide can be carried out by any one of the well-known methods in the technical field. For example, it can be designed simply by utilizing known genome sequence data and universal primer design tool. As this primer design tool, for example, Primer3 that can be utilized on the network is arranged. In addition, known genome sequence data can be obtained in NCBI as an international base sequence database usually.

[0017] In one aspect of the present invention, the method for diagnosing fertility defects provided by the present invention includes the step of detecting TMEM232 protein, such as detecting the expression of the protein (including whether it exists, and whether there is a phenomenon of reduced expression relative to normal or standard) or its activity.

[0018] In another aspect of the present invention, the method includes a step of determining the expression of the TMEM232 protein by immunoassay. For example, the expression of TMEM232 is detected by immunofluorescence or Western blotting with an antibody that specifically recognizes the protein. For another example, the expression of TMEM232 is detected by detecting the presence or amount of mRNA of the protein, such as by detecting the amount of mRNA encoding TMEM232 in a sample by RT-PCR.

[0019] In yet another aspect of the present invention, the method comprises the step of determining the activity of the TMEM232 protein.

[0020] The present invention also provides a kit or instrument and device (including a gene chip) for diagnosing or predicting fertility defects such as infertility in a mammalian individual, which includes a reagent for detecting Tmem232 in the subject.

[0021] In another aspect of the present invention, the kit or instrument includes a reagent for detecting the expression or activity of the TMEM232 protein. For example, the kit or instrument includes a reagent for immunoassay, such as an ELISA or Western blot performed by an antibody that specifically recognizes the protein to detect the expression of TMEM232. For another example, the kit or instrument includes a reagent for detecting the expression of the TMEM232 by detecting the presence or quantity of the mRNA of the protein, such as a reagent for detecting the amount of mRNA encoding TMEM232 in a sample by RT-PCR.

[0022] In yet another aspect of the present invention, the kit or apparatus comprises a reagent for detecting the Tmem232 gene.

[0023] In one aspect of the present invention, in the above-mentioned methods, kits or instruments of the present invention, the reagents for detecting genetic markers in samples include primers or probes for detecting Tmem232, or reagents for examining TMEM232, such as specific antibodies or reagents for detecting the mRNA of the protein.

[0024] In the present invention, there is also provided the use of a reagent for detecting Tmem232 in preparing a kit or instrument for diagnosing or predicting fertility defects such as infertility in a mammalian individual as described above. The reagent for detecting genetic markers includes a primer or probe for detecting the Tmem232 gene, or a reagent for checking the TMEM232 protein, such as a specific antibody or a reagent for detecting the mRNA of the protein.

[0025] The present invention also provides a method for treating or avoiding fertility defects in a mammalian individual, which comprises treating an individual having a Tmem232 deficiency, such as a Tmem232 mutation.

[0026] In this article, protein symbols are not italicized and are all capitalized; gene symbols are italicized. For example, TMEM232 is a protein, and the gene encoding the protein is written as Tmem232. Sometimes protein symbols are not all capitalized in this article. For example, sometimes "Tmem232" in this article means TMEM232 protein. Sometimes gene symbols are not italicized in this article. For example, sometimes "Tmem232" or "TMEM232 gene" in this article means the gene Tmem232 encoding TMEM232 protein. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1The expression profiles of Tmem232 in brain (Br), heart (He), liver (Li), spleen (Sp), lung (Lu), kidney (Ki), uterus (Ut), ovary (Ov), testis (Te), epididymis (Ep) tissues of adult mice, as well as testis of different ages.

[0028] Figure 2 The construction of Tmem232 whole-body knockout mice is shown. Figure 2 a is a schematic diagram of constructing Tmem232 whole-body knockout mice using CRISPR / CAS9 gene editing technology. Figure 2 b shows the results of identifying the genotype of the offspring of gene-edited mice by DNA polymerase chain reaction.

[0029] Figure 3 It showed that the sperm deformation in the testis of Tmem232 knockout male mice was normal. Figure 3 a shows the results of PAS staining of the testes of 3-month-old wild-type and Tmem232KO male mice, P, pachytene spermatocyte, rSt, round spermatid, spz, spermatid, eSt, elongated spermatozoon, D, zygotic spermatocyte, M, metaphase of the second meiotic division, n=3. Figure 3 b shows the sperm stages 1-16 of 3-month-old wild-type and Tmem232 whole-body knockout male mice, n=3.

[0030] Figure 4 It was shown that Tmem232 knockout male mice were infertile. Figure 4 a shows that 2-month-old wild-type male mice and Tmem232 KO male mice were housed with 2-month-old wild-type female mice for 3 months to test their fertility, n=3. Figure 4 b shows that 2-month-old wild-type female mice and Tmem232KO female mice were caged with 2-month-old wild-type male mice for 3 months to test their fertility, n=3.

[0031] Figure 5 It showed that the number of epididymal sperm in Tmem232 knockout male mice was reduced. Figure 5 a shows H&E staining of epididymis paraffin sections of 3-month-old wild-type and Tmem232KO male mice, n=3. Figure 5 b shows the sperm counts in the cauda epididymis of 3-month-old wild-type and Tmem232 KO male mice, n = 3.

[0032] Figure 6 It showed that sperm motility was reduced in Tmem232 knockout male mice. Figure 6 a shows that the proportion of motile sperm decreased significantly. Figure 6 b shows no forward motility of sperm. Figure 6 c and Figure 6d are the average sperm motility (VAP) and linear motility (VSL) diagrams, respectively, showing that the motility of Tmem232 KO sperm is significantly reduced compared with the sperm of wild-type male mice.

[0033] Figure 7 This is a scanning electron microscopy ultrastructural analysis of sperm from Tmem232 knockout male mice. Figure 7 a shows that the sickle-shaped sperm head has a normal shape, and the double helix structure of the mitochondrial sheath is arranged normally and tightly connected. Figure 7 b shows that the junction between the middle segment and the main segment of the flagellum is normal, the fiber sheath of the main segment develops normally, and the lines of the wild-type flagellum are smooth. Figure 7 c shows that the head of Tmem232 KO sperm is bent, a large abnormal vesicle structure appears in the middle section, and the middle section of the sperm is bent and cannot straighten. Figure 7 d shows the large vesicle in the midpiece of Tmem232 KO sperm;. Figure 7 e and Figure 7 f shows the large vesicle organization in the mid-piece of Tmem232 KO sperm. The vesicle membrane structure surrounds the sperm tail, causing the sperm tail to be entangled. Figure 7 g shows that multiple sperms of Tmem232 KO are fused together. Figure 7 h shows that multiple sperms of Tmem232 KO were fused, and the axoneme at the junction of the sperm midpiece and the main segment was exposed without being covered by flagellar accessory structures, n = 3.

[0034] Figure 8 This is a transmission electron microscopy analysis of sperm from Tmem232 knockout male mice. Figure 8 a shows the longitudinal section of WT sperm showing the normal arrangement structure of mitochondria in the midpiece of sperm. Figure 8 b shows the normal anulus structure (yellow arrow) and normal fiber sheath structure of the main junction in the sperm flagellum. Figure 8 c shows a cross section of WT sperm, where each flagellum has an independent cell membrane structure. Figure 8 d shows a large vesicle in the midpiece of Tmem232 KO sperm, which contains many disordered mitochondrial structures, electron-dense substances, and independent large vacuoles (red asterisks). Figure 8 e shows a longitudinal section of the long axis of Tmem232 KO sperm, showing that the axoneme at the main junction in the sperm is exposed without covering by accessory structures (red arrow). Figure 8 f shows that multiple sperms of Tmem232 KO fused and shared the same cell membrane, n = 3.

[0035] Fig. 9 It showed that the sperm of Tmem232 knockout male mice showed extrusion of the axoneme and ODF. Fig. 9a shows the co-staining of anti-ODF2 antibody and anti-α-tubulin antibody by immunofluorescence analysis of sperm smears from the cauda epididymis of 3-month-old wild-type and Tmem232 systemic knockout male mice. Fig. 9 b shows the results of scanning electron microscopy analysis of spermatozoa in the cauda epididymis of 3-month-old wild-type and Tmem232 systemic knockout male mice.

[0036] Fig.10 To show that TMEM232 interacts with ODF1, HEK293T cells were transfected with Tmem232-3×HA alone or co-transfected with Tmem232-3×HA and Odf1-3×FLAG, and anti-FLAG antibody was added, and IgG was used as a control for in vitro co-IP experiments. DETAILED DESCRIPTION

[0037] The essential contents and beneficial effects of the present invention will be further described below in conjunction with embodiments, which are only used to illustrate the present invention rather than to limit the present invention.

[0038] Example 1 Establishment of animal model

[0039] The mouse Tmem232 gene (transcript: ENSMUST00000062161) is 284.77 kb in length, contains 16 exons, and is located on chromosome 17. Exon 4 is the ATG start codon, and exon 16 is the TGA stop codon. A 21844 bp gene fragment from exon 4 to exon 8 was selected for knockout. The gene knockout mouse model (Tmem232KO, C57BL / 6J) was constructed by Suzhou Saiye Biotechnology Co., Ltd. using CRISPR / Cas9 gene editing technology. Tmem232 homozygous gene knockout mice Tmem232 KO were obtained by mating male and female mice with the genotype of Tmem232 Het. All offspring were cut by cutting the mouse toe tissue to extract total DNA, and the genotype was identified by agarose gel electrophoresis after polymerase chain reaction (PCR) amplification. The identification primer DNA sequences are: forward primer: 5-AGCAAT CTGTCTTTCCAGTGGG-3, reverse primer 1: 5-ACCAAAGAGACTGAAGTGGTC-3, reverse primer 2: 5-AGACCCACATTCTTTGCTTGAG-3. All mice used in the experiments were selected from wild-type and Tmem232 KO mice of the same litter, aged 2 to 3 months, and the mice were raised in the same SPF (specific pathogen-free) environment. Animal experiments strictly followed the guidelines of the Animal Care and Use Committee of Shandong University.

[0040] Example 2 Experimental methods and reagents

[0041] Genotyping of mouse toe tissue

[0042] Cut 1-2 mm of the toes of mice 5-7 days after birth, put them into a 1.5 mL EP tube, add 150 μL of lysis buffer to each sample, and digest overnight or for 12-15 hours in a 55°C water bath. The components of 10×Lysis Buffer include Tris-HCl, EDTA and NaCl. Take out the digested mouse toes, vortex for 30 seconds, denature in a 95°C metal bath for 15 minutes, and centrifuge at 12000 rpm for 30 seconds to obtain crude tissue DNA.

[0043] Design Tmem232 primer sequence:

[0044] Forward primer: 5-AGCAATCTG TCTTTCCAGTGGG-3,

[0045] Reverse Primer 1: 5-ACCAAAGAGACTGAAGTTGGTC-3,

[0046] Reverse Primer 2: 5-AGACCCACAT TCTTTGCTTGAG-3.

[0047] The total DNA of the sample was amplified by polymerase chain reaction (PCR), and the genotype of the sample was detected by agarose gel electrophoresis.

[0048] Real-time quantitative PCR

[0049] Tissue RNA extraction

[0050] Total RNA kit extraction method: according to Instructions for use of the Cell / Tissue Total RNA Isolation Kit.

[0051] RNA reverse transcription and RT-PCR

[0052] according to Reverse transcription was performed according to the instructions of III RT SuperMix Kit.

[0053] Tmem232 RT-PCR primer sequences:

[0054] Forward primer: 5-AGTGCAAAGGGGAGATCC AA-3;

[0055] Reverse primer: 5-GGTTGACTTCGTAGCCCCTC-3.

[0056] Gapdh RT-PCR primer sequences:

[0057] Forward primer: 5-GCCTTCTCCATGGTGGTGAA-3;

[0058] Reverse primer: 5-GCACAGTCA AG GCCGAGAAT-3.

[0059] The amplified samples were visualized by agarose gel electrophoresis.

[0060] Observation of sperm motility and morphology

[0061] Sperm count

[0062] After the mice were killed by cervical dislocation, the cauda epididymis and the 2-3 cm vas deferens connected to it were immediately dissected out, and the tissue was immediately placed in 1 mL of sperm capacitation solution preheated at 37°C, cut into pieces, and released at 37°C for 30 min. The upper layer of semen was gently blown to make the sperm fully and evenly dispersed. 10 μL of semen was aspirated and injected into the blood cell counting plate, and the number of sperm in 4 large squares was counted. The sperm density was calculated according to the dilution multiple.

[0063] Sperm motility test

[0064] After the mice were killed by cervical dislocation, the tail of the epididymis and the 2-3 cm vas deferens connected to it were immediately dissected out, and the tissue was immediately placed in 1 mL of sperm capacitation solution preheated at 37°C, fully cut into pieces, and released at 37°C for 30 minutes. The upper layer of semen was gently blown to make the sperm fully and evenly dispersed, 20 μL of semen was drawn and injected into a special slide of the sperm motility analyzer, and the slide was placed in the sperm motility analyzer. The computer-assisted sperm analysis (CASA) system was used to analyze sperm motility and record the report. CASA can analyze the proportion of active sperm in a field of view, the proportion of forward-moving sperm, the velocity of curved movement (VCL), the velocity of linear movement (VSL), the average path velocity (VAP) and other data reflecting the sperm movement pattern.

[0065] Sperm morphology observation

[0066] Mice were killed by cervical dislocation to release sperm in the cauda epididymis and heated in a 60°C water bath for 5 min. 10 μL of semen was dropped on a glass slide and spread evenly with a gun tip. The slide was dried naturally at room temperature to prepare a sperm smear. Sperm morphology was observed using a confocal microscope in DIC mode.

[0067] Preparation of paraffin sections of testicular epididymal tissue

[0068] (1) Testicular and epididymal tissue collection: Mice were killed by cervical dislocation, and the testicles and epididymis were immediately dissected, the surrounding adipose tissue was removed, and the weight was weighed.

[0069] (2) Tissue fixation: Choose different fixation methods according to specific experimental requirements. Bohr's solution fixation: Place the removed tissue in 5-6 mL of Bohr's solution and fix it at 4°C overnight; Paraformaldehyde fixation: Place the removed tissue in 5-6 mL of 4% paraformaldehyde and fix it at 4°C overnight.

[0070] (3) Tissue dehydration: The tissue is dehydrated through different concentrations of alcohol, then transparentized through xylene, and finally placed in paraffin to complete tissue dehydration.

[0071] (4) Tissue sectioning: Adjust the section thickness to 5 μm, continue slicing to cut out continuous wax strips, and bake for more than 4 h. After completion, store the slides in a -20°C refrigerator for subsequent experimental operations.

[0072] H&E staining of paraffin sections of testis and epididymis and sperm smears

[0073] (1) Slice baking: After taking out the slices (fixed with Bohr's solution) from the -20°C refrigerator, place them on a 65°C slice baking machine and bake for 1 h.

[0074] (2) Dewax the tissue sections and place them in single distilled water.

[0075] (3) Smear fixation: Soak the naturally dried smear in 95% ethanol for 15 min, let it dry naturally at room temperature, and store it in a -80°C low-temperature refrigerator.

[0076] (4) Smear rewarming: After the smear is taken out of the -80°C freezer, it is rewarmed to room temperature and then immersed in PBS.

[0077] (5) Hematoxylin staining: Soak the dewaxed sections in hematoxylin staining solution for 5 min, then rinse them in tap water.

[0078] (6) Color separation and blueing: Soak the tissue slide in 0.5% hydrochloric acid alcohol for 1 to 2 seconds, then immediately rinse in tap water for 3 to 5 minutes.

[0079] (7) Eosin staining: Place the tissue sections that have returned to blue in eosin staining solution for 1 min, then place them in tap water for 1 min, and then dehydrate them step by step.

[0080] (8) Sealing: Add a small drop of neutral gum on the tissue, cover with a coverslip, place in a fume hood, and wait for the slices to dry naturally.

[0081] Testis epididymis paraffin sections and sperm smear immunofluorescence staining

[0082] Immunofluorescence staining of paraffin sections of testis and epididymis

[0083] (1) Baked slices: slices were fixed with 4% paraformaldehyde.

[0084] (2) Dewax the tissue sections and place them in single distilled water.

[0085] (3) Tissue section antigen repair: Rinse the dewaxed tissue sections in single distilled water to ensure that the pH is 7.4. Then soak the sections in 10 μM sodium citrate antigen repair solution (pH = 6.0), place the staining jar in boiling water for 30 minutes, take it out, and let it cool at room temperature.

[0086] (4) Tissue permeabilization: circle the tissue with an immunohistochemical pen, add 0.1% Triton × 100, and incubate for 15 minutes.

[0087] (5) Primary antibody incubation: The primary antibody dilution was the same as the blocking solution, and the primary antibody dilution concentration was anti-α-tubulin antibody (1:1000, F2168, Sigma-Aldrich).

[0088] (6) Secondary antibody incubation: Add fluorescent secondary antibody and incubate at room temperature for 1 h. The secondary antibody dilution solution is PBS, and the secondary antibody dilution concentration is 1:1000.

[0089] (7) Sealing and observation: Add DAPI to seal the slides and observe under a confocal microscope.

[0090] Immunofluorescence staining of sperm smear

[0091] (1) Smear rewarming: After the smear is taken out of the -80℃ freezer, it is rewarmed to room temperature and then immersed in PBS.

[0092] (2) Cell permeabilization: circle the area with an immunohistochemical pen, add 0.1% Triton×100, and incubate for 15 min.

[0093] (3) Primary antibody incubation. The primary antibody dilution was the same as the blocking solution, anti-α-tubulin antibody (1:1000, F2168, Sigma-Aldrich), rabbit anti-ODF2 antibody (1:1000, 12058-1-AP, Proteintech).

[0094] (4) Secondary antibody incubation: Add fluorescent secondary antibody. The secondary antibody dilution solution is PBS, and the secondary antibody dilution concentration is 1:1000.

[0095] (5) Sealing and observation: Add DAPI to seal the slides and observe under a confocal microscope.

[0096] PAS glycogen staining of testis paraffin sections

[0097] (1) Glycogen PAS staining kit is used for PAS glycogen staining.

[0098] (2) Slice baking: After taking out the slices (fixed with Bohr's solution) from the -20°C refrigerator, place them on a 65°C slice baking machine and bake for 1 hour.

[0099] (3) Dewaxing of tissue sections: Place the paraffin sections into the dewaxing tank one at a time and place them into single distilled water after dewaxing is completed.

[0100] (4) Tissue oxidation: Add oxidant dropwise, leave at room temperature for 5-8 minutes, rinse once with tap water, and then rinse twice with distilled water.

[0101] (5) Tissue staining: Add Schiff staining solution to the tissue circle, place it away from light, and stain for 10 to 20 minutes. The tissue staining status can be checked during the staining process. After staining is completed, rinse with tap water for 10 minutes.

[0102] (6) Hematoxylin staining and differentiation: Soak the glycogen-stained sections in hematoxylin staining solution for 5 min, then rinse them in tap water for 3 min; soak the tissue in 0.5% hydrochloric acid alcohol for 1 to 2 s, then rinse them in tap water to turn them blue.

[0103] (7) Dehydrate the tissue, seal the slides, and allow the sections to dry naturally.

[0104] Co-immunoprecipitation

[0105] (1) Extract protein.

[0106] (2) Add 4-10 μg of antibody to each tube of extracted protein, seal the tube tightly, and incubate overnight at 4°C and 15 rpm.

[0107] (3) Wash the agarose beads.

[0108] (4) Add agarose beads: Quickly add 30 μL of beads to the protein-antibody EP tube. Seal tightly and incubate at 4°C, 15 rpm for 1 hour. Afterwards, temporarily store in a 4°C refrigerator.

[0109] (5) Washing agarose beads:

[0110] (6) Sample electrophoresis: Subsequent steps are the same as Western blot.

[0111] Scanning electron microscopy of epididymal sperm and transmission electron microscopy of testicular epididymis

[0112] Sperm tissue samples were sent to the Electron Microscope Center of Zhejiang University for sample preparation and photography

[0113] Statistical methods

[0114] Paired t-test was used to indicate whether the differences between different genotypes were statistically significant, with mean ± SEM. P < 0.05 (*), 0.01 (**) or 0.001 (***) indicated statistically significant differences.

[0115] Example 3 TMEM232 is an evolutionarily conserved testis-enriched protein

[0116] Comparison using the BLAST (Basic Local Alignment Search Tools) tool in the NCBI database showed that the TMEM232 protein sequence is highly conserved in mammals such as mice, chimpanzees, rats, humans, cows, and dogs.

[0117] In order to analyze the expression level of Tmem232 mRNA in various organs and tissues, multiple organs of adult mice were sampled and RNA from each organ was extracted. RT-PCR experiments were performed, and the conclusions were consistent with those in the NCBI database. The results showed that Tmem232 mRNA was expressed most highly in the testis, and was expressed in the brain, liver, spleen, lung, uterus, kidney and epididymis, but the expression was weak; no expression was detected in the heart and ovary. In order to analyze the expression level of Tmem232 mRNA in the testis at different stages, the testis samples were collected starting from the 8th day after birth of the mouse, and the testis samples were collected at 8, 12, 21, 35, and 56 days after birth, respectively, to capture the various periods of the first wave of spermatogenesis in the testis, and RNA from the testis samples was extracted for RT-PCR experiments.

[0118] The results are as follows Figure 1 The results showed that Tmem232 mRNA expression began to increase significantly 21 days after birth, which roughly corresponds to the stage when sperm transform into haploid round spermatids after meiosis.

[0119] These results indicate that TMEM232 is a testis-enriched protein whose function is conserved during spermatogenesis.

[0120] Example 4 Tmem232 knockout leads to male mouse infertility

[0121] In order to study the function of Tmem232 gene in vivo, the whole body knockout mouse of Tmem232 was constructed by using CRISPR / CAS9 gene editing technology. The mouse Tmem232 gene transcript has 16 exons, and exons 4 to 8 were selected as the knockout target sequence ( Figure 2 a).

[0122] The genotypes of the offspring of gene-edited mice were identified by DNA polymerase chain reaction: the Tmem232 locus in wild-type male mice was 572 bp, while the locus in Tmem232 knockout (Tmem232 KO) male mice was 424 bp ( Figure 2 b).

[0123] Further experiments were conducted to detect potential phenotypic changes after Tmem232 knockout in adult male mice. It was found that there was no significant difference in the size and morphology of the testis and epididymis between wild-type and Tmem232 KO male mice. There was also no significant difference in the testis weight, mouse body weight, and the ratio of testis weight to mouse body weight between Tmem232 KO mice and wild-type mice.

[0124] To further analyze the effect of Tmem232 knockout on the sperm deformation process, PAS glycogen staining was performed on the testes of wild-type mice and Tmem232 knockout mice. During the gradual deformation and maturation of sperm, the acrosome tissue in the sperm cells also gradually matured. According to the acrosome development status after PAS staining, the seminiferous tubules of stages 1-12 were divided and analyzed and observed, and the sperm of stages 1-16 in the seminiferous tubules were also analyzed and observed separately. Compared with wild-type mice, there were no obvious abnormalities in the development of the seminiferous tubules of the testes of Tmem232 KO mice from stage 1 to stage 12 ( Figure 3 a), sperm in the seminiferous tubules at stage 8-9, sperm release is normal. There is no significant difference in the acrosome development process of sperm heads at stage 1-16 between the knockout mice and the wild-type controls ( Figure 3 b).

[0125] To test the fertility of Tmem232 knockout mice, 2-month-old male wild-type mice and Tmem232 KO male mice were housed with 2-month-old female wild-type mice for 3 months, and the number of offspring was counted.

[0126] The results showed that wild-type female mice cohabiting with Tmem232 KO male mice did not become pregnant and no offspring were born ( Figure 4 a). In contrast, 2-month-old male wild-type mice were co-housed with 2-month-old Tmem232 KO female mice and wild-type female mice for 3 months, and the number of offspring was counted. Tmem232 KO female mice were fertile, with an average litter size of 7.3±1.7 (n=3), which was not significantly different from the fertility of wild-type female mice ( Figure 4 b).

[0127] It can be seen that Tmem232 knockout will cause infertility in male mice, but will not affect the fertility of female mice.

[0128] Example 5 Tmem232 knockout leads to abnormal sperm morphology and reduced sperm motility

[0129] In order to explore the cause of male infertility, the sperm in the epididymis of Tmem232 KO male mice was studied in depth. H&E staining of paraffin sections of the epididymis tail showed that compared with wild-type male mice, the number of sperm in the epididymis tail of Tmem232 KO male mice was reduced, and a small number of apoptotic cells appeared in the epididymis tail ( Figure 5 a). After counting the sperm released from the cauda epididymis of wild-type male mice and Tmem232 KO male mice, it was found that the number of sperm in Tmem232 KO male mice was significantly reduced ( Figure 5 b).

[0130] The morphological analysis of individual sperm was then performed, and it was found that the sperm of Tmem232 KO male mice had abnormalities compared to the sperm of wild-type male mice. After analysis, the abnormalities in sperm morphology were mainly divided into three categories, and statistics were taken for these three types of sperm: 41.43% of sperm had a "hairpin" structure in the middle section of the sperm flagellum, 11.97% of sperm were aggregated into bundles, and 8.31% of sperm suddenly narrowed at the junction of the middle section and the main section, with a flagellum that was not covered by an accessory structure.

[0131] The sperm motility was further analyzed by computer-assisted semen analysis (CASA). It was found that the proportion of active sperm in Tmem232 KO male mice was significantly decreased compared with sperm from wild-type mice ( Figure 6 a), no forward-moving sperm ( Figure 6 b). At the same time, two other important indicators representing sperm motility were also analyzed, namely the average sperm velocity (VAP) and the linear velocity (VSL). It was also found that the motility of Tmem232 KO sperm was significantly reduced compared with the sperm of wild-type male mice ( Figure 6 c and Figure 6 d).

[0132] Example 6 Tmem232 knockout leads to abnormal sperm cytoplasm removal

[0133] In order to further explore the effect of Tmem232 KO on sperm flagella, the ultrastructure of sperm flagella in the tail of the epididymis was observed by scanning electron microscopy and transmission electron microscopy. The results of scanning electron microscopy showed that the cell membrane of sperm flagella of wild-type male mice was smooth, the double helix structure of the mitochondrial sheath in the middle section of the flagellum was arranged neatly and tightly, the middle section of the flagellum and the main section were connected normally, and the fiber sheath structure of the main section was normal ( Figure 7 a and b), but in contrast, the sperm flagella of Tmem232 KO male mice have abnormal structures: a large vesicle structure exists in the middle of some sperm flagella ( Figure 7 cf), some sperm have a 180° bend in the middle due to the presence of the vesicle, and the sperm head is facing the sperm tail ( Figure 7 c) Some sperm tails are tangled due to the presence of vesicles ( Figure 7 e,f). In addition, some sperm were observed to aggregate into bundles ( Figure 7 g, h), and some sperm are exposed at the junction of the mid-segment and the main segment, without any covering of accessory structures ( Figure 7 h).

[0134] Transmission electron microscopy analysis showed that the mitochondrial sheaths in the longitudinal section of the midsection of the sperm flagellum of wild-type mice were closely arranged ( Figure 8 a) The middle and main segments of the flagellum are tightly connected, and the anulus structure is normal ( Figure 8 b), each sperm has an independent cell membrane ( Figure 8 c). In the middle of some Tmem232 KO sperm, there is a large vesicle, which is consistent with the results of scanning electron microscopy. The vesicle contains a large number of disordered mitochondria, independent large vacuoles, and black electron-dense substances ( Figure 8 d asterisk). Judging from the ultrastructure of the vesicle, the vesicle is a cytoplasmic structure that remains during the sperm deformation process. Under normal circumstances, most of the sperm cytoplasm should be engulfed by the supporting cells during the sperm deformation process; the longitudinal section of some sperm flagella shows that the middle-main junction is narrowed and not covered by the accessory structure, but the anulus structure still exists ( Figure 8 e arrow); multiple sperm flagella are fused into bundles and share a cell membrane ( Figure 8 f).

[0135] The above results indicate that Tmem232 knockout will lead to sperm cytoplasm removal disorders, and Tmem232 plays an important role in sperm cytoplasm removal.

[0136] Example 7 Tmem232 knockout leads to loss of doublet microtubule 7 around the sperm flagellar axoneme

[0137] In the process of ultrastructural analysis of the cross-sections of the middle, main and tail segments of the flagellum of the epididymal tail sperm, it was found that compared with wild-type sperm, the cross-section of the mitochondrial sheath in the middle segment had no obvious abnormalities, the peripheral dense fibers (ODF) were normal, the fiber sheath structure and ODF of the main segment were normal, and the "9+2" microtubule structure of the axoneme in the middle, main and tail segments of the flagellum was intact. Compared with the epididymal tail sperm of Tmem232 KO male mice, the cross-section observation of the mitochondrial sheath and the fiber sheath had no obvious abnormalities, but the 7th peripheral doublet microtubule in the "9+2" microtubule structure of the axoneme in the middle, main and tail segments was fixedly missing, and the corresponding ODF was also missing. The naming method of the 9 peripheral microtubules is that the peripheral microtubule that intersects the vertical line connecting the central microtubule is number 1, and is counted in the reverse direction of the dynein arm.

[0138] In order to explore the period when this fixed loss occurs, transmission electron microscopy of testicular tissue was collected and it was found that some sperm of Tmem232KO also had a fixed loss of microtubule 7. Further statistical analysis of flagella with missing microtubule 7 showed that only 10% of sperm in the testis lacked microtubule 7, compared with 88% of sperm in the cauda epididymis that lacked microtubule 7.

[0139] It can be seen that during the transfer of sperm from the testis to the epididymis, the loss of microtubule 7 and its corresponding ODF increased significantly, and Tmem232 plays an important role in maintaining the integrity of the sperm flagellar axoneme.

[0140] Example 8: Interaction between TMEM232 and ODF1

[0141] The peripheral dense fibers (ODF) are one of the special appendages of the sperm flagellum and surround the axoneme of the midpiece and the main segment. To determine whether the loss of peripheral microtubules 7 is related to the peripheral dense fibers, the status of peripheral dense fibers and flagellar axonemes in individual sperms was observed by immunofluorescence analysis by co-staining with ODF2 antibodies and α-tubulin antibodies. It was observed that ODF and tubulin were squeezed out from the sperm head-tail junction and the midpiece-main segment junction ( Fig. 9 a). At the same time, scanning electron microscopy analysis of epididymal tail sperm showed that ODF and tubulin were squeezed out from the sperm head-tail junction and the junction of the mid-segment and main segment ( Fig. 9 b).

[0142] Several components of peripheral dense fibers have been identified, including ODF1, ODF2, and ODF3. Among them, the main component and the only testis-specific expressed protein component is ODF1. In this experiment, ODF1 was selected as the research object. The mouse Odf1 gene was inserted into the pCMW-3×Flag plasmid vector to construct an overexpression plasmid of the mouse Odf1 gene. The mouse Tmem232 gene was inserted into the pCMW-3×HA plasmid vector to construct an overexpression plasmid of the mouse Tmem232 gene, which was transfected into HEK293T cells to overexpress ODF1 and TMEM232 proteins.

[0143] In vitro co-immunoprecipitation (co-IP) analysis was performed in HEK293T cells and found that TMEM232 interacted with ODF1 in HEK293T cells ( Fig.10 ).

[0144] The inventors of this application discovered for the first time that Tmem232 is essential for the fertility of male mice. The inventors showed through a series of experimental analyses that Tmem232 plays an important role in the removal of cytoplasm during sperm formation and in maintaining the integrity of the sperm flagellar axoneme and its accessory tissues. Tmem232 gene knockout leads to abnormal sperm morphology and flagellar structure, which in turn leads to abnormal sperm motility, affecting the fertility of male mice. The inventors revealed that male mice lacking Tmem232 have reduced sperm motility and male infertility, and analyzed the reasons for the reduction in sperm motility from the aspects of sperm morphology and sperm ultrastructure, and provided ideas for the reasons for changes in sperm ultrastructure.

[0145] Applicants have thus provided methods for diagnosing fertility defects such as infertility disorders in mammals, including humans, and further facilitated the development of new treatments for male infertile individuals affected by gene mutations.

[0146] The above is an explanation of the present invention and cannot be regarded as a limitation of the present invention. Unless otherwise noted, the practice of the present invention will use the conventional techniques of organic chemistry, polymer chemistry, biotechnology, etc., and it is obvious that the present invention can also be realized in other ways except that it is particularly described in the above description and embodiments. Other aspects and improvements within the scope of the present invention will be apparent to those skilled in the art to which the present invention belongs. According to the teachings of the present invention, many changes and variations are feasible, and therefore they are within the scope of the present invention.

Claims

1. Use of a reagent for detecting Tmem232 in a subject in the preparation of a kit or an apparatus for diagnosing and predicting the risk of fertility defects such as infertility in mammals.

2. The method of claim 1, wherein the infertility disorder is selected from teratozoospermia, azoospermia, oligozoospermia, asthenozoospermia, and asthenozoospermia.

3. The use according to claim 1, wherein the kit further comprises a reagent for detecting the gender of the subject.

4. The use according to any one of claims 1 to 3, wherein the reagent for detecting Tmem232 in the subject is a reagent for detecting the Tmem232 gene.

5. The use according to any one of claims 1 to 3, wherein the reagent for detecting Tmem232 in the subject is a reagent for detecting TMEM232 protein, and preferably, further comprising a reagent for determining the activity of TMEM232.

6. The use according to claim 5, comprising a reagent for detecting the expression of TMEM232 by immunoassay, such as a reagent for detecting the expression of TMEM232 by ELISA or Western blotting using an antibody that specifically recognizes the protein; or These include reagents for detecting TMEM232 by detecting the presence or amount of TMEM232 mRNA, such as reagents for detecting the amount of mRNA encoding TMEM232 in a sample by RT-PCR.

7. A kit or device (such as a gene chip) for diagnosing and predicting the risk of meiosis-related diseases, especially fertility defects or infertility, in mammals of different sexes, comprising a reagent for detecting Tmem232 of a test individual, and preferably, also comprising a reagent for detecting the sex of the test individual.

8. The kit or device according to claim 7, wherein the reagent for detecting Tmem232 of the subject is a reagent for detecting the Tmem232 gene.

9. The kit or device according to claim 7, wherein the reagent for detecting Tmem232 in the subject is a reagent for detecting TMEM232 protein, and preferably, further comprising a reagent for measuring the activity of TMEM232.

10. The kit or device of claim 9, comprising a reagent for determining TMEM232 by immunoassay, such as an antibody that specifically recognizes TMEM232; or The invention includes a reagent for detecting the presence or amount of TMEM232 mRNA to detect the expression of TMEM232, such as a reagent for detecting mRNA encoding TMEM232 in a sample by RT-PCR.

Citation Information

Cited By

  • Kit for key protein of sperms with embryonic development potential and use method of kit

    CN121231785A